Investors are often on the lookout for innovative companies since there are often considerable upsides in the long term, and a company that could have such potential is Pressure Biosciences Inc. (OTC:PBIO). The company is best known for being the leading innovator in the field of unique pressure-based instruments that could be deployed across a range of industries.
Yesterday, the company announced that Uncle Bud’s Health and Wellness, its fully owned direct-to-consumer subsidiary, had decided to embark on an expansion of its products and categories in 2024 to the ‘Premium Collection’ of advanced nanoemulsified products. The ‘Premium Collection’ had been formed recently by Uncle Bud’s. In the news release yesterday, it was noted that the ‘Premium Collection’ had been designed to offer the highest form of innovation in the realm of quality and performance in the latest generation of nanoemulsion products. It was also noted that, as an organization, Uncle Bud’s continued to be committed to organic, preservative-free, clean, and completely natural wellness products.
The company further announced in its news release yesterday that, in addition to providing a major boost in terms of performance, the new collection of products had also been processed with the patented UltraShear Technology platform from Pressure Biosciences. Nowadays, there are many wellness and health products that contain oil-soluble compounds.
Owing to the poor solubility of these compounds, these products are known for poor absorption, bioavailability, and onset for consumers. The first product that had been offered under the Premium Collection was a Body Revive Spray meant for full recovery, and it had proven to be an instant success. The product meant for full recovery of joints, muscles, and the body contained as much as 1200 mg of UltraShear-processed Nano-CBD. It could be a good move to add Pressure Biosciences to your watch lists today.
